Humana Inc. HUM
397.93
17.61
4.63%
as of 25 Sep
- Market cap
- $45.7B
- P/E
- 37.4×
Follow HUM
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Humana Inc. (HUM) P/E ratio
As of 25 September 2026, Humana Inc. (HUM) trades at a P/E ratio of 37.4×. Over the past ten years it has ranged from 10.6× (March 2020) to 55.1× (March 2017); the current reading is higher than 97% of that period. That is above the Healthcare Plans industry median of 23.8× and above the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 26.0× | 2.49% |
| FY2024 | 25.4× | 7.67% |
| FY2023 | 23.6× | 4.39% |
| FY2022 | 22.6× | 11.01% |
| FY2021 | 20.4× | 26.31% |
| FY2020 | 16.1× | (11.28%) |
| FY2019 | 18.2× | (22.40%) |
| FY2018 | 23.4× | 56.16% |
| FY2017 | 15.0× | (69.81%) |
| FY2016 | 49.7× | 137.25% |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 37.3× | 101.99% |
| Mar 2026 | 18.5× | (29.06%) |
| Dec 2025 | 26.0× | 6.95% |
| Sep 2025 | 24.3× | 30.01% |
| 42 more quarters | Free account |
Against its own ten years
Low 10.6×
High 55.1×
Ten-year median
20.9×
Current reading's percentile
97
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CLOV Clover Health Investments, Corp. compare | n/m |
| MOH Molina Healthcare, Inc compare | n/m |
| CNC Centene Corporation compare | n/m |
| CI Cigna Group compare | 11.3× |
| OSCR Oscar Health, Inc. compare | 17.3× |
| ELV Elevance Health, Inc. compare | 17.6× |
| CVS CVS Health Corporation compare | 23.3× |
| UNH UnitedHealth Group Incorporated compare | 24.2× |
| HUM Humana Inc. | 37.4× |
| Healthcare Plans industry median | 23.8× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on HUM
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement